SCIENTIFIC PROGRAM
August 01, 2026 (Saturday)
August 02, 2026 (Sunday)
| 15th National Haemostasis Update (NHU 2026) | ||||
|---|---|---|---|---|
| (The timings mentioned are as per the Indian Standard Time - IST) | ||||
| Time (IST) | Topic | |||
| 07:30 - 08:20 AM | Registration | |||
| 08:20 - 08:30 AM | Opening remarks | |||
| 08:30 - 09:50 AM | Scientific Session 1: Clotting Factor Therapies Chair: Dr. R K Nigam |
|||
| 08:30 - 08:45 AM | Extended Half-Life (EHL) Prophylaxis: Optimising Dosing Intervals and Trough Targets in the Era of Personalised Care Speaker: Dr. Nita Radhakrishnan |
|||
| 08:45 - 08:50 AM | Discussion | |||
| 08:50 - 09:05 AM | Surgery & Critical Care with EHL Products: Perioperative Protocols and Pitfalls Speaker: Dr. S. P. Verma |
|||
| 09:05 - 09:10 AM | Discussion | |||
| 09:10 - 09:25 AM | Co - Morbidities in Haemophilia Speaker: Dr. Sunita Aggarwal |
|||
| 09:25 - 09:30 AM | Discussion | |||
| 09:30 - 09:45 AM | Relevance of Global Haemostasis in Clinical Practice Speaker: Dr. Akshatha Pandiri |
|||
| 09:45 - 09:50 AM | Discussion | |||
| 09:50 - 10:50 AM | Scientific Session 2: Inhibitors Chair: Dr. Shashikant Apte |
|||
| 09:50 - 10:10 AM | Strategies to Reduce Inhibitor Development Moderator: Dr. Anupam Dutta Subject Expert: Dr. Johnny Mahlangu Panelist: Dr. Ankur Jain Dr. Athulya B Asokan Dr. Aruna Rajendra |
|||
| 10:10 - 10:25 AM | Perioperative Management in Haemophilic Patients with Inhibitors on Non Factor Therapies Speaker: Dr. Aby Abraham |
|||
| 10:25 - 10:30 AM | Discussion | |||
| 10:30 - 10:45 AM | Unusual Cases of Haemophilia with Inhibitors (Lab Perspective) (Case-Based Discussions) Speaker: Dr. Jasmita |
|||
| 10:45 - 10:50 AM | Discussion | |||
| 10:50 - 11:20 AM | Tea Break with Poster Viewing | |||
| 11:20 - 12:20 PM | Novo Nordisk | |||
| 12:20 - 03:40 PM | Scientific Session 3: Non Factor Therapies Chair: Dr. Kundan Mishra |
|||
| 12:20 - 12:40 PM | FVIIIa Mimetics - What are the Similarities and Differences? Speaker: Dr. Hitha B |
|||
| 12:40 - 12:50 PM | Discussion | |||
| 12:50 - 01:10 PM | Rebalancing Agents - Similarities, Differences and How to Choose? Speaker: Dr. M Joseph John |
|||
| 01:10 - 01:20 PM | Discussion | |||
| 01:20 - 02:00 PM | Lunch | |||
| 01:30 - 02:30 PM | Roche | |||
| 02:30 - 03:40 PM | Scientific Session 3: Non Factor Therapies Chair: Dr. Dr. Anand Prakash |
|||
| 02:30 - 02:50 PM | Laboratory Monitoring of Non-Factor Therapies and EHL: Do's and Don'ts Speaker: Dr. Rajesh Phatale |
|||
| 02:50 - 03:00 PM | Discussion | |||
| 03:00 - 03:30 PM | HTA Assessment: Indian Scenario (10 min each) | |||
| a) ICMR / DHR Speaker: Dr. Kavita Rajshekar |
||||
| b) JIPMER Speaker: Dr. Sitanshu Kar |
||||
| c) Pooled Analysis Report Speaker: Dr. Rucha Patil |
||||
| 03:30 - 03:40 PM | Discussion | |||
| 03:40 - 04:40 PM | Sanofi | |||
| 04:40 - 05:10 PM | Tea Break with Poster Viewing | |||
| 05:10 - 06:10 PM | Scientific Session 4: Rare Bleeding Disorders Chair: Dr. Vandana Bharadwaj |
|||
| 05:10 - 05:30 PM | Platelet Disorders: Diagnosis, Management and Novel Therapies Speaker: Dr. K K Radhika |
|||
| 05:30 - 05:40 PM | Discussion | |||
| 05:40 - 06:00 PM | Rare Bleeding Disorders: Indian Perspective Speaker: Dr. Arihant Jain |
|||
| 06:00 - 06:10 PM | Discussion | |||
| 06:10 - 07:10 PM | Scientific Session 5: Acquired Bleeding Disorders Chair: Dr. Karthika KV |
|||
| 06:10 - 06:30 PM | Acquired Haemophilia Speaker: Dr. Sanjeevan Sharma |
|||
| 06:30 - 06:40 PM | Discussion | |||
| 06:40 - 07:05 PM | Panel Discussion: Adapting Nursing Care and Physiotherapy in the Era of Non-Factor Therapies Moderator: Dr. Varun Kaul Panelist: Dr. Parul Bhatt Dr. Sheikh Bilal Mr. Siju Paul Ms. Geeta Suri Sharma Mr. Abraham Sunder Singh |
|||
| 07:05 - 07:10 PM | Discussion | |||
| 07:30 PM | Dinner | |||
| 15th National Haemostasis Update (NHU 2026) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| (The timings mentioned are as per the Indian Standard Time - IST) | ||||||||||
| Time (IST) | Topic | |||||||||
| 08:30 - 10:30 AM | Hall A Physician | Hall B Musculoskeletal | Hall C Nursing | Hall D Laboratory | ||||||
| Session 6a: Recent Advances Chair: Dr. Dnyaneshwar Upase |
08:30 - 10:30 AM | Session 6b Chair: Dr. Shigy Francis |
Session 6c Chair: Mr. Abraham Sunder Singh |
08:30 - 10:30 AM | Session 6d Chair: Dr. Sukesh C Nair |
|||||
| 08:30 - 08:50 AM | Disability Guidelines Speaker: Dr. Tulika Seth |
08:30 - 08:45 AM | Acute Bleed Management (Joint & Muscle) Speaker: Ms. Merlyn Tilak |
Adapting Haemophilia Nursing Roles to meet the Needs of Women with Bleeding Disorder Speaker: Dr. Sulochana K (PhD) |
08:30- 8:45 AM | a. Role of CTLA-4 (Cytotoxic T-Lymphocyte-Associated Protein 4), PD-1 (Programmed Death-1), ICOS (Inducible T-cell Costimulator) in Inhibitor Development in Hemophilia A. Speaker: Dr. Rashmi Kushwaha b. Audit Of Factor Viii Bethesda Inhibitor Assay: A Two Year Experience. Speaker: Dr. Megha Sawhney c. Clinico-Pathological Spectrum of Glanzmann Thrombasthenia Speaker: Dr. Shalini Singh |
||||
| 08:50 - 09:00 AM | Discussion | 08:45 - 08:55 AM | Discussion | Discussion | 08:45 - 08:55 AM | Q&A | ||||
| 09:00 - 09:20 AM | Carrier Testing, Prenatal Diagnosis: Ethics & Algorithm Speaker: Dr. Cecil Ross |
08:55 - 09:10 AM | Management of Chronic Synovitis Speaker: Ms. Geeta Suri Sharma |
Transition of Hemophilia Care- Role of Haemophilia Nurse Speaker: Ms. Kavitha S Nair |
08:55 - 09:15 AM | Improve Inhibitor testing - no misses and amisses Speaker: Dr. Tulasi Geevar |
||||
| 09:20 - 09:30 AM | Discussion | 09:10 - 09:20 AM | Discussion | Discussion | 09:15 - 09:25 AM | Discussion | ||||
| 09:30 - 09:50 AM | Definitions of prophylaxis and ABR recording and reporting- New ISTH SSC Recommendations Speaker: Dr. Alok Srivastava |
09:20 - 09:35 AM | Total Knee Replacement Speaker: Mr. Sandeep Kumar |
Panel Discussion: The Haemophilia Nurse as “Therapy Navigator” Moderator: Ms. Divya Varghese Panelists: a. Dr. S P Verma c. Dr. Shanthala Devi A.M d. Ms. Nishchitha Rao e. Ms. Upasana Gohain f. Dr. Mathangi Kumar |
09:25 - 09:45 AM | Monitoring of Non Factor Therapies in Haemophilia Speaker: Dr. Dinesh Chandra |
||||
| 09:50 - 10:00 AM | Discussion | 09:35 - 09:45 AM | Discussion | 09:45 - 09:55 AM | Discussion | |||||
| 10:00 - 10:20 AM | Debate: Gene Therapy Vs Non Factor Therapy Speaker: Dr. Varun Bafna & Dr. Chandrakala S |
09:45 - 10:00 AM | Post Total Knee Replacement Rehabilitation Speaker: Ms. Andriya R |
09:55 - 10:10 AM | Basic Approach for testing for Mutation testing of Haemophilia A and MLPA Speaker: Dr. Debadrita Ray |
|||||
| 10:20 - 10:30 AM | Discussion | 10:00 - 10:10 AM | Discussion | Discussion | 10:10 - 10:20 AM | Improvements in Genetic testing in Haemophilia Speaker: Dr. Bipin Kulkarni |
||||
| 10:10 - 10:25 AM | Functional Assessment Tools For Early Joint Disease In Haemophilia Speaker: Ms. Rohini Dange |
Discussion | 10:20 - 10:30 AM | Combined Discussion | ||||||
| 10:25 - 10:30 AM | Discussion | Discussion | ||||||||
| 10:30 - 11:00 AM | Tea Break with Poster Viewing | |||||||||
| 11:00 - 12:00 PM | Novo Nordisk- Hall A | Takeda- Hall B | ||||||||
| 12:00 - 01:00 PM | Oral Abstracts - Hall A | Oral Abstracts - Hall B | ||||||||
| 01:00 - 02:00 PM | Lunch | |||||||||
| 02:00 - 03:00 PM | HALL A | |||||||||
| Scientific Session 7: Women with Bleeding Disorders Chair: Dr. Anju Mehrotra Kadu |
||||||||||
| 02:00 - 02:20 PM | Overview: Women & Girls with Bleeding Disorder - Prevalence, Diagnostic Challenges, ISTH-BAT Scoring and the Indian Context Speaker: Dr. Dinesh Chandra |
|||||||||
| 02:20 - 02:30 PM | Discussion | |||||||||
| 02:30 - 02:50 PM | Case Based Lecture on: i) Management of Gynecological Health in Women & Girls with Bleeding Disorder Speaker: Dr. Ana Boban ii) Obstetric Health in Women & Girls with Bleeding Disorder Speaker: Dr. Meera V |
|||||||||
| 02:50 - 03:00 PM | Discussion | |||||||||
| 03:00 - 03:10 PM | Closing remarks & Departure | |||||||||
Sponsored Symposium
- Novo Nordisk click here
- Roche click here
- Sanofi click here
- Takeda click here
More details coming soon
SCIENTIFIC PROGRAM
August 02, 2025 (Saturday)
August 03, 2025 (Sunday)
| 14th National Haemostasis Update (NHU 2025) | ||||
|---|---|---|---|---|
| (The timings mentioned are as per the Indian Standard Time - IST) | ||||
| Time (IST) | Topic | |||
| 12:00 - 01:00 PM | Symposium I - Novo Nordisk | |||
| 01:00 - 02:00 PM | Registration & Lunch | |||
| 02:00 - 02:10 PM | Opening remarks | |||
| 02:10 - 03:40 PM | Scientific Session 1 Chair: Dr. Tulika Seth |
|||
| 02:10 - 02:30 PM | Low Dose Emicizumab with Drug Level Monitoring. Speaker: Dr. Chandrakala S |
|||
| 02:30 - 02:40 PM | Q&A | |||
| 02:40 - 03:00 PM | A Case Study: Comorbidities in Older Patients with Haemophilia. Speaker: Dr. M Joseph John |
|||
| 03:00 - 03:10 PM | Q&A | |||
| 03:10 - 03:40 PM | Case Studies- Presentation/ Work up /Management & Surgeries in: | |||
| 1) Glanzmann Thrombasthenia Speaker: Dr. Mukul Aggarwal |
||||
| 2) Factor XIII Speaker: Dr. Vandana Bhardwaj |
||||
| 3) Afibrinogenemia Speaker: Dr. Anupam Dutta |
||||
| 03:40 - 04:00 PM | Tea Break with Poster Viewing | |||
| 04:00 - 05:15 PM | Scientific Session 2: Recent Updates in Laboratory Diagnosis and Monitoring of Haemophilia Chair: Dr. Sanjeevan Sharma |
|||
| 04:00 - 04:15 PM | Monitoring of Extended Half-Life Factor Concentrates. Speaker: Dr. Dinesh Chandra |
|||
| 04:15 - 04:25 PM | Q&A | |||
| 04:25 - 04:40 PM | Laboratory Testing in Haemophilia Patients in the Era of Non-Factor Replacement Therapies. Speaker: Dr. Tulasi Geevar |
|||
| 04:40 - 04:50 PM | Q&A | |||
| 04:50 - 05:05 PM | PoC for Diagnosis of Haemophilia and von Willebrand disease. Speaker: Dr. Bipin Kulkarni |
|||
| 05:05 - 05:15 PM | Q&A | |||
| 05:15 - 06:15 PM | Symposium II - Novo Nordisk | |||
| 06:15 - 07:30 PM | Scientific Session 3 Chair: Dr. Neeraj Sidharthan |
|||
| 06:15 - 06:35 PM | Congenital Bleeding Disorders; Pregnancy and Delivery. Speaker: Dr. Huyen Tran |
|||
| 06:35 - 06:40 PM | Q&A | |||
| 06:40 - 07:00 PM | Acquired Haemophilia. Speaker: Dr. Aby Abraham |
|||
| 07:00 - 07:05 PM | Q&A | |||
| 07:05 - 07:25 PM | Case Based Discussion and Newer Management of von Willebrand Disease. Speaker: Dr. Tadashi Matsushita |
|||
| 07:25 - 07:30 PM | Q&A | |||
| 07:30 - 08:00 PM | Poster Viewing | |||
| 08:00 PM | Dinner | |||
| 14th National Haemostasis Update (NHU 2025) | ||||||
|---|---|---|---|---|---|---|
| (The timings mentioned are as per the Indian Standard Time - IST) | ||||||
| Time (IST) | Topic | |||||
| 07:30 - 8:30 AM | Hall A | Hall B | Hall C | |||
| Oral Abstracts | Oral Abstracts | |||||
| 08:30 - 10:30 AM | Hall A Physician |
Hall B Musculoskeletal |
Hall C Nursing |
|||
| Session 4a Chair: Dr. Cecil Ross |
Session 4b Chair: Dr. Shigy Francis |
Session 4c Chair: Dr. Anjalin D’Souza |
||||
| 08:30 - 08:50 AM | Case based discussion: Bleeding Disorder of Unknown Cause. Speaker: Dr. Mrilanini Kotru |
Management of Knee Flexion Deformity in Patients with Haemophilia. Speaker: Dr. Padma kumar G |
Nursing Frameworks in Haemophilia Care.
1) St. John's Hospital 2) Post Graduate Institute for Child Health 3)Assam Medical College 4) CMC Ludhiana Speaker: Ms. Kavitha Nair Ms. Divya Varghese Ms. Sunita Rani Ms. Upasana Gohain Ms. Minakshi Daliya |
|||
| 08:50 - 09:00 AM | Q&A | Q&A | ||||
| 09:00 - 09:20 AM | Bleeding Scores. Speaker: Dr. Sukesh C Nair |
Acute Elbow Bleed Management and Post Bleed Sequelae. Speaker: Ms. Geeta Suri Sharma |
||||
| 09:20 - 09:30 AM | Q&A | Q&A | Q&A | |||
| 09:30 - 09:50 AM | Suspected Bleeding Disorder in Heavy Menstrual Bleed- Approach & Management. Speaker: Dr. Renu Saxena |
Management of Balance Impairment in Patients with Haemophilia. Speaker: Ms. Rohini Dange |
Nursing Research in Haemophilia- Present and Future. Speaker: Dr. Sulochana B |
|||
| 09:50 - 10:00 AM | Q&A | Q&A | ||||
| 10:00 - 10:20 AM | NGS Utility, Diagnosis & Pitfalls. Speaker: Dr. Ashwin Dalal |
Guidelines for Post-Amputation in Patients with Haemophilia. Speaker: Ms. Merlyn Tilak |
Understanding Bleeding Disorders in Women and Girls. Speaker: Ms. Anbu Jeba |
|||
| 10:20 - 10:30 AM | Q&A | Q&A | Q&A | |||
| 10:30 - 11:00 AM | Tea Break with Poster Viewing | |||||
| 11:00 - 12:00 PM | Symposium III- Roche | Symposium IV- Takeda | ||||
| 12:00 - 01:00 PM | HALL A | |||||
| Scientific Session 5 Chair: Dr. Shashikant Apte |
||||||
| 12:00 - 12:20 PM | Care of Adolescent/ Young Adult; Psychosocial and Genetic Counseling Speaker: Dr. Meera V |
|||||
| 12:20 - 12:30 PM | Q&A | |||||
| 12:30 - 12:50 PM | Gene Therapy in India. Speaker: Dr. Alok Srivastava |
|||||
| 12:50 - 01:00 PM | Q&A | |||||
| 01:00 - 01:10 PM | Closing Remarks | |||||
| 01:15 PM onwards | Lunch and departure | |||||
Sponsored Symposium
- Novo Nordisk click here
- Novo Nordisk click here